Resultaten visas 1 - 10 / 90
resultat / per sida
Vilka publikationsuppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År

Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasms

Referentgranskad
Chalandon Y; Eikema D; Moiseev I; Ciceri F; Koster L; Vydra J; Passweg J; Rovira M; Ozcelik T; Gedde...
Blood Advances2024

Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasms

Referentgranskad
Öppen tillgång
DOI
10.1182/bloodadvances.2024013468
Chalandon, Yves; Eikema, Diderik-Jan; Moiseev, Ivan Sergeevich; Ciceri, Fabio; Koster, Linda; Vydra,...
Blood Advances2024

Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation

Referentgranskad
DOI
10.1182/blood.2019000487
Battipaglia, Giorgia; Labopin, Myriam; Kroeger, Nicolaus; Vitek, Antonin; Afanasyev, Boris; Hilgendo...
Blood2019

Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation

Referentgranskad
Öppen tillgång
DOI
10.1016/j.jtct.2021.11.013
Nagler, Arnon; Labopin, Myriam; Dholaria, Bhagirathbhai; Wu, Depei; Choi, Goda; Aljurf, Mahmoud; Cic...
Transplantation and cellular therapy2022

The impact of individual comorbidities in transplant recipients receiving post-transplant cyclophosphamide

Referentgranskad
DOI
10.1038/s41409-025-02514-4
Spyridonidis, Alexandros; Labopin, Myriam; Savani, Bipin P.; Kulagin, Alexander; Blaise, Didier; Bro...
Bone Marrow Transplantation2025

Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus

Referentgranskad
DOI
10.1038/mt.2011.113
Cerullo, Vincenzo; Diaconu, Iulia; Kangasniemi, Lotta; Rajecki, Maria; Escutenaire, Sophie; Koski, A...
Molecular therapy2011

Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients

Öppen tillgång
DOI
10.1002/hem3.70190
Bröckelmann, Paul J.; Böll, Boris; Molin, Daniel; Schneider, Gundolf; Leppä, Sirpa; Meissner, Julia;...
HemaSphere2025

ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?

Referentgranskad
Öppen tillgång
DOI
10.1038/s41375-024-02225-7
Penack, Olaf; Abouqateb, Mouad; Peczynski, Christophe; Boreland, William; Kröger, Nicolaus; Stelljes...
Leukemia2024

Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Referentgranskad
DOI
10.1002/cncr.35004
Giebel, Sebastian; Labopin, Myriam; Salmenniemi, Urpu; Socie, Gerard; Bondarenko, Sergey; Blaise, Di...
Cancer2023

Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach

Referentgranskad
DOI
10.1016/j.ijbiomac.2023.124749
Narendra Gera, Raju Baddipadige, Verma Himanshu, Kumar Manoj, Jain Subheet Kumar, Tung Gurleen Kaur,...
International Journal of Biological Macromolecules2023

Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasms

Referentgranskad
2024

Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasms

Referentgranskad
Öppen tillgång
DOI
10.1182/bloodadvances.2024013468
2024

Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation

Referentgranskad
DOI
10.1182/blood.2019000487
2019

Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation

Referentgranskad
Öppen tillgång
DOI
10.1016/j.jtct.2021.11.013
2022

The impact of individual comorbidities in transplant recipients receiving post-transplant cyclophosphamide

Referentgranskad
DOI
10.1038/s41409-025-02514-4
2025

Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus

Referentgranskad
DOI
10.1038/mt.2011.113
2011

Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients

Öppen tillgång
DOI
10.1002/hem3.70190
2025

ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?

Referentgranskad
Öppen tillgång
DOI
10.1038/s41375-024-02225-7
2024

Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Referentgranskad
DOI
10.1002/cncr.35004
2023

Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach

Referentgranskad
DOI
10.1016/j.ijbiomac.2023.124749
2023